Task: Answer the multiple-choice question.
Question: Which drug exhibits a 16.733\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCC(C)NCCOc1ccc(Br)cc1.O=C(O)C(=O)O
b.) COCCCNC(=S)N1CCN(C)CC1
c.) COc1cc(CN2CCCC(N3CCN(c4ccccc4C)CC3)C2)ccc1O
d.) CCCCn1c(N)c(N(CC(C)C)C(=O)CC(NC(=O)c2ccccc2)c2ccccc2)c(=O)[nH]c1=O
e.) CCCNC(=O)C(CC)NC(=O)c1cccc([N+](=O)[O-])c1
Answer: e. CCCNC(=O)C(CC)NC(=O)c1cccc([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)C(CC)NC(=O)c1cccc([N+](=O)[O-])c1
CCCNC(=O)C(CC)NC(=O)c1cccc([N+](=O)[O-])c1
oxido-oxo-[3-[[1-oxo-1-(propylamino)butan-2-yl]carbamoyl]phenyl]azanium